Notice of Extra General Meeting of Genovis AB (publ)

Report this content

A request of an Extra General Meeting has been received from a shareholder, holding more than 10 percent of the total shares in Genovis AB. The request the shareholder asks upon the Extra General Meeting is the item election of new board of directors in Genovis AB.

Shareholders of GENOVIS AB (publ) are hereby summoned to an Extra General Meeting (EGM) to be held on July 21, 2011, at 5:00 p.m. at Scheelevägen 22, Lund, Sweden.

Participation

To be entitled to participate in the business of the Meeting, shareholders must be recorded in the register of shareholders maintained by Euroclear Sweden AB (former VPC AB, the Swedish Securities Register Center) on July 15, 2011, and must notify Genovis of their intention to attend the Meeting no later than July 15, 2011.

Nominee-registered shares

Shareholders whose shares are registered in the name of a nominee through the trust department of a bank or similar institution must, in order to be entitled to participate in the Meeting, request that their shares are temporarily re-registered in their own names in the register of shareholders maintained by Euroclear Sweden AB. Such registration must be effected, July 15, 2011.

Shareholders are requested to inform their nominees well in advance of this date.

Notification

  • mail to GENOVIS AB (publ), Box 270, 220 07 Lund
  • telephone +46 (0)46-10 12 30/38
  • fax +46 (0)46-12 80 20
  • e-mail: info@genovis.com

When registering, shareholders should state their:

  • name/company name
  • personal identification or corporate identity number
  • address, telephone number
  • name and personal identification number of any representatives
  • name of the attendance of any assistants

Agenda

  1. Opening of the meeting.
  1. Election of chairman for the meeting.
  1. Preparation and approval of voting list.
  1. Approval of the agenda.
  1. Election of two persons to attest to the accuracy of the minutes.
  1. Decision on whether proper notice of the Meeting has been made.
  1. Decisions on the number of Members and Deputy Members of the Board of Directors, who shall be appointed by the Meeting.
  1. Election of Members of the Board of Directors.
  1. Conclusion of the Meeting.

Shareholders are reminded of their right to request information according to Chapter 7, § 32

Lund July, 2011

Board of Directors, Genovis AB

For more information, please contact: Sarah Fredriksson, CEO, Genovis AB Tel: 46 46 10 12 35 sarah.fredriksson@genovis.com

Genovis develops and designs smart nanoparticles for preclinical imaging and diagnostics and also develops and sells tools for modification of antibodies.Genovis shares are listed on Nasdaq OMX First North and Thenberg & Kinde Fondkommission ( 46 (0)31 745 50 00) is the Company’s certified adviser.

Subscribe

Documents & Links